Arginine vasopressin in 316 patients with advanced vasodilatory shock

Critical Care Medicine

Volumn 33, Issue 11, 2005, Pages 2659-2666

  Luckner, Günter ^a   Dünser, Martin W ^a   Jochberger, Stefan ^a   Mayr, Viktoria D ^a   Wenzel, Volker ^a   Ulmer, Hanno ^a   Schmid, Stefan ^a   Knotzer, Hans ^a   Pajk, Werner ^a   Hasibeder, Walter ^b   Mayr, Andreas J ^a   Friesenecker, Barbara ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Krankenhaus der Barmherzigen Schwestern Ried Betriebsgesellschaft mbH   (Austria)

Author keywords

Arginine vasopressin; Bilirubin; Cardiac index; Liver enzymes; Mortality; Norepinephrine; Platelets; Septic shock; Side effects; Vasodilatory shock

Indexed keywords

ADRENALIN; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ARGIPRESSIN; BILIRUBIN; LIVER ENZYME; MILRINONE; NORADRENALIN;

ACUTE HEART INFARCTION; ACUTE PANCREATITIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CARDIOGENIC SHOCK; CARDIOPULMONARY HEMODYNAMICS; CAUSE OF DEATH; COMPARATIVE STUDY; CORONARY VASCULAR RESISTANCE; DRUG INFUSION; HEART FAILURE; HEMOFILTRATION; HUMAN; HYPOVOLEMIC SHOCK; ISCHEMIC COLITIS; LABORATORY TEST; LIVER FAILURE; LIVER NECROSIS; LUNG EMBOLISM; LUNG INSUFFICIENCY; MEAN ARTERIAL PRESSURE; MEDICAL ASSESSMENT; MEDICAL EXAMINATION; MESENTERIC BLOOD VESSEL OCCLUSION; MORTALITY; MULTIPLE ORGAN FAILURE; NEUROTOXICITY; PANCREAS INJURY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE COUNT;

EID: 27944450050     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000186749.34028.40     Document Type: Review

References (38)

1. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345:588-595
2. Dellinger RP: Cardiovascular management of septic shock. Crit Care Med 2003; 31:946-955
3. Parillo J: Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328:1471-1477
4. Chen P: Vasopressin: New uses in critical care. Am J Med Sci 2002; 324:146-154
5. Wenzel V, Krismer AC, Arntz HR, et al: A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 2004; 350:105-113
6. Holmes CL, Landry DW, Granton JT: Science Review: Vasopressin and the cardiovascular system part 2. Clinical physiology. Crit Care 2004; 8:15-23
7. Dünser MW, Wenzel V, Mayr AJ, et al: Management of vasodilatory shock: Defining the role of arginine vasopressin. Drugs 2003; 63:237-256
8. Patel BM, Chittock DR, Russell JA, et al: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96:576-582
9. Dünser MW, Mayr AJ, Ulmer H, et al: Arginine vasopressin in advanced vasodilatory shock: A prospective, randomized, controlled study. Circulation 2003; 107:2313-2319
10. Russell JA, Cooper DJ, Walley KR, et al: Vasopressin and Septic Shock Trial (VASST): Baseline characteristics and organ dysfunction in vasopressor dependent patients with septic shock. Am J Respir Crit Care Med 2003; 167:A548
11. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
12. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiologic Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
13. Goris RJ, te Boekhorst TP, Nuytinck JK, et al: Multiple-organ failure: Generalized autodestructive inflammation? Arch Surg 1985; 120:1109-1115
14. Laird NM, Ware JH: Random-effects models for longitudinal data. Biometrics 1982; 38:963-974
15. Dünser MW, Mayr AJ, Ulmer H, et al: The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: A retrospective analysis. Anesth Analg 2001; 93:7-13
16. Dünser MW, Mayr AJ, Stallinger A, et al: Cardiac performance during vasopressin infusion in postcardiotomy shock. Intensive Care Med 2002; 28:746-751
17. Dünser MW, Mayr AJ, Tür A, et al: Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: Incidence and risk factors. Crit Care Med 2003; 31:1394-1398
18. Appel PL, Kram HB, Mackabee J, et al: Comparison of measurements of cardiac output by bioimpedance and thermodilution in severely ill surgical patients. Crit Care Med 1986; 14:933-935
19. Landry DW, Levin HR, Gallant EM, et al: Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997; 25:1279-1282
20. Westphal M, Stubbe H, Sielenkämper AW, et al: Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep. Crit Care Med 2003; 31:1502-1508
21. Scharte M, Meyer J, van Aken H, et al: Hemodynamic effects of terlipressin (a synthetic analogue of vasopressin) in healthy and endotoxemic sheep. Crit Care Med 2001; 29:1756-1760
22. Holmes CL, Walley KR, Chittock DR, et al: The effects of vasopressin on hemodynamics and renal function in severe septic shock: A case series. Intensive Care Med 2001; 27:1416-1421
23. O'Brien A, Clapp L, Singer M: Terlipressin for norepinephrine-resistant septic shock. Lancet 2002; 359:1209-1210
24. Schlee H, Prondzinsky R, Osten B, et al: Systemic inflammatory reactions to extracorporeal therapy measures: Hemodialysis and hemofiltration. Wien Klin Wochenschr 1997; 109:301-311
25. Hamada Y, Karjalainen A, Setchell BA, et al: Concomitant stimulation by vasopressin of biliary and perfusate calcium fluxes in the perfused rat liver. Biochem J 1992; 281:387-392
26. Ballatori N, Truong AT: Cholestasis, altered junctional permeability, and inverse changes in sinusoidal and biliary glutathione release by vasopressin and epinephrine. Mol Pharmacol 1990; 38:64-71
27. Hamada Y, Karjalainen A, Bygrave FL: Hormone-induced bile flow and hepatobiliary calcium fluxes are attenuated in the perfused liver of rats made cholestatic with ethynylestradiol in vivo and with phalloidin in vitro. Hepatology 1995; 21:1455-1464
28. Henrion J, Schapira M, Luwaert R, et al: Hypoxic hepatitis: Clinical and hemodynamic study in 142 consecutive cases. Medicine 2003; 82:392-406
29. Seeto RK, Fenn B, Rockey DC: Ischemic hepatitis: Clinical presentation and pathogenesis. Am J Med 2000; 109:109-113
30. Asfar P, Pierrot M, Veal N, et al: Low-dose terlipressin improves systemic and splanchnic hemodynamics in fluid-challenged endotoxic rats. Crit Care Med 2003; 31:215-220
31. Sun Q, Dimopoulos G, Nguyen DN, et al: Low dose vasopressin in the treatment of septic shock in sheep. Am J Respir Crit Care Med 2003; 168:481-486
32. Westphal M, Freise H, Kehrel BE, et al: Arginine vasopressin compromises gut mucosal microcirculation in septic rats. Crit Care Med 2004; 32:194-200
33. Martikainen TJ, Tenhunen JJ, Uusaro A, et al: The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock. Anesth Analg 2003; 97:1756-1763
34. Van Haren FM, Rozendaal FW, van der Hoeven JG: The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 2003; 124:2256-2260
35. Dünser MW, Fries DR, Schobersberger W, et al: Does arginine vasopressin influence the coagulation system in advanced vasodilatory shock with severe multiorgan dysfunction syndrome? Anesth Analg 2004; 99:201-206
36. Mulder J, Tan HK, Bellomo R, et al: Platelet loss across the hemofilter during continuous hemofiltration. Int J Artif Organs 2003; 26:906-912
37. Biccard BM, Gopalan PD: Phaeochromocytoma and acute myocardial infarction. Anaesth Intensive Care 2002; 30:74-76
38. Goldspink DF, Burniston JG, Clark WA, et al: Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of rat in vivo: The same or separate death pathways? Exp Physiol 2004; 89:407-416